The company#39;s topical manufacturing facility at Ahmedabad has received an EIR from the United States Food and Drug Administration (USFDA) signifying the successful closure of the audit, Cadila Healthcare said in a filing to the BSE.Cadila Healthcare gets EIR from USFDA for its Ahmedabad facility
The company#39;s topical manufacturing facility at Ahmedabad has received an EIR from the United States Food and Drug Administration (USFDA) signifying the successful closure of the audit, Cadila Healthcare said in a filing to the BSE.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment